Elsevier

Heart & Lung

Volume 42, Issue 3, May–June 2013, Pages 163-170
Heart & Lung

Care of Patients with Chronic Pulmonary Disorders
Frailty in people with COPD, using the National Health and Nutrition Evaluation Survey dataset (2003–2006)

https://doi.org/10.1016/j.hrtlng.2012.07.004Get rights and content

Abstract

Background

Little is known about frailty in people with chronic obstructive pulmonary disease (COPD). The purposes of this study were to describe frailty, to identify, which demographic and clinical characteristics contributed to frailty, and to examine the relationship between frailty and health-related outcomes in people with COPD.

Methods

This was a secondary cross-sectional study, using data from the National Health and Nutrition Evaluation Survey. The frailty index and outcome measures were derived primarily from survey responses.

Results

The prevalence of frailty was 57.8%. Multivariate logistic regression showed that individuals with COPD who had self-reported shortness of breath and comorbid diabetes were more likely to be frail than those who did not. Frail people tended to have a greater number of disabilities.

Conclusions

The findings support the importance of frailty in the COPD population. Further study is needed to understand frailty in people with COPD, using objective measures for criteria of frailty.

Introduction

Frailty is associated with the decline of physiologic reserves in multiple systems and the inability to respond to stressful insults.1 Evidence suggests that frailty contributes to falls, disability, and mortality in the general population of older adults.2 Less is known about frailty in people with chronic diseases such as chronic obstructive pulmonary disease (COPD). People with COPD experience marked deficits in muscle strength and mass3 and impaired functional status,4 which places them at risk for frailty. No studies to date have described frailty in detail from the viewpoint of people who are living with COPD, although frailty has been shown to have a strong association with COPD as a comorbidity.5, 6, 7

Absent a precise definition or measure of frailty, the condition has been generally viewed in two ways.8 One view focuses on frailty's physical aspect, such as the phenotype of frailty introduced by Fried.2 The other view defines frailty as a condition that is characterized by multidimensional deficits over time.9 For example, Gobbens et al10 define frailty as “a dynamic state affecting an individual who experiences losses in one or more domains of human functioning (physical, psychological, and social)” (p. 176). It is caused by a range of variables, and increases the risk of adverse outcome. Their definition emphasizes the dynamic nature and multifactorial aspects of frailty. Based on the several analyses of frailty that have been conducted,11 most researchers now agree that the concept of frailty should be multidimensional; it should account for the interrelationship of individual factors (i.e., physical and psychological); and it should acknowledge a person's individual context. Gobben et al's definition incorporates these dimensions. Although several conceptual frameworks for frailty have been advanced,12 we used Gobbens et al's9 frailty model to guide our research (Fig. 1), because it is consistent with our understanding of the phenomenon. In addition to describing a distinct relationship between frailty and adverse outcomes, this model illustrates how frailty and adverse outcomes can be affected by multiple personal characteristics.

Studies have described the factors that contribute to frailty in older people.13 Although most studies have used different conceptual frameworks and definitions of frailty, several factors have emerged as significant contributors to the condition. Older age,2, 5, 6, 14, 15, 16 particularly in people aged 85 and older16; female gender; and race, being an African American, have been related to frailty.2, 6, 16, 17 A lower level of education,2, 5, 15, 17 lower income,2, 6, 18 and poorer health perception have also been associated with frailty.2, 14, 15, 19 Chronic diseases, such as COPD, diabetes, peripheral vascular disease, heart failure, and osteoarthritis, and multimorbidity have been significantly associated with frailty.2, 14, 15, 17, 18, 19 Strawbridge et al19 and Rome-Ortuno et al15 found that frail people tended to have more symptoms.

Frailty in the general population has been associated with health-related outcomes. Frail individuals had higher rates of disability than those who were not frail.2, 16, 20 Frailty was significantly associated with impairment in activities of daily living (ADL) and instrumental activities of daily living (IADL) disability.2, 14, 15, 20 Furthermore, one cohort study21 found that frail people had a significantly higher risk of developing new-onset dependency for ADL than non-frail people. Frail people were more likely to have visits to the emergency department, admission to the hospital, and more contact with physicians.14, 15 The age-adjusted odds ratio for mortality has been shown to be 4.8 for women and 6.9 for men in a frail group compared with non-frail group.15

The relationship between frailty and chronic disease is complicated. Research has described frailty from the perspective of people with advanced chronic disease.7, 22, 23 The odds of frailty were substantially higher in people with chronic kidney disease than in those without and frailty was related to the severity of chronic kidney disease.7 Cardiovascular disease, particularly congestive heart failure, has been associated with an increased likelihood of frailty.22 In addition, it has been suggested that insulin resistance is associated with frailty.24

Researchers have also reported that one frailty marker, decreased strength, significantly predicted toxicity from cancer treatments, including chemotherapy and radiotherapy, in older people with cancer25 and that preoperative frailty was associated with an increased risk of postoperative complications and length of hospital stay in older patients.26 Death was found to be progressively more prevalent in frail patients with congestive heart disease than in frail people without the disease.27

Chronic obstructive pulmonary disease is an irreversible and progressive disease, and people with COPD will experience intermittent exacerbation, characterized by acute deterioration in chronic dyspnea and functional limitation. As with people who have other advanced chronic diseases, people with COPD are more likely to be frail.5, 6, 7 The current study attempts to better understand frailty in the COPD population, including its contributing factors and outcomes. Its findings will aid the development of a more tailored and effective intervention to delay frailty, thereby improving function and minimizing disability in this population.

The purposes of this study were: (1) to describe frailty, (2) to examine the relative contribution of demographic and clinical characteristics to frailty, and (3) to examine the relationship between frailty and health-related outcomes (e.g., ADL/IADL disability and health care utilization) in people with COPD.

Section snippets

Design

Data from the National Health and Nutrition Evaluation Survey (NHANES) were used for this cross-sectional study. NHANES is a nationally representative, ongoing survey of the health status of persons residing in the United States.28 The NHANES data were collected using a multistage, stratified, clustered probability design to obtain a representative sample of non-institutionalized civilians in the United States. In the NHANES, certain populations were oversampled, including low income persons,

Results

The final analytic sample comprised 211 persons (Fig. 2). Of those, 98 people had chronic bronchitis, 70 had COPD, and 43 had both diseases. The mean age of the total sample (n = 211) was 70.65 years. The sample was predominantly non-Hispanic Whites and evenly split between men and women (Table 2). Twenty-eight percent (n = 60) were still smoking.

Discussion

To our knowledge, this is the first study to describe frailty in people with COPD and to use objectively measured physical activity as a component of frailty. In this study, the prevalence of frailty was high and the strongest predictor of frailty was self-reported shortness of breath. Frailty was significantly associated with ADL and IADL disability.

The prevalence of frailty was higher than in the general population of older adults18 and people with chronic kidney disease.7 However the

Acknowledgments

This study was supported by T32 Post Doctoral Fellowship; Health Promotion/ Risk Reduction Interventions with Vulnerable Populations Training Grant in University of Michigan, Ann Arbor.

References (56)

  • T. Troosters et al.

    Physical inactivity in patients with COPD, a controlled multi-center pilot-study

    Respir Med

    (2010)
  • V.Z. Dourado et al.

    Relationship of upper-limb and thoracic muscle strength to 6-min walk distance in COPD patients

    Chest

    (2006)
  • J.M. Yentes et al.

    Walking abnormalities are associated with COPD: an investigation of the NHANES III dataset

    Respir Med

    (2011)
  • C.D. Blinderman et al.

    Symptom distress and quality of life in patients with advanced chronic obstructive pulmonary disease

    J Pain Symptom Manage

    (2009)
  • M.T.E. Puts et al.

    Does frailty predict hospitalization, emergency department visits, and visits to the general practitioner in older newly-diagnosed cancer patients? Results of a prospective pilot study

    Crit Rev Oncol Hematol

    (2010)
  • L.P. Fried et al.

    Untangling the concepts of disability, frailty, and comorbidity: implications for improved targeting and care

    J Gerontol A Biol Sci Med Sci

    (2004)
  • L.P. Fried et al.

    Frailty in older adults: evidence for phenotype

    J Gerontol A BiolSci Med Sci

    (2001)
  • M. Roig et al.

    Deficits in muscle strength, mass, quality, and mobility in people with chronic obstructive pulmonary disease

    J Cardiopulm Rehabil Prev

    (2011)
  • D.M. Mannino et al.

    Obstructive and restrictive lung disease and functional limitation: data from the third national health and nutrition examination

    J Intern Med

    (2003)
  • C.S. Blaum et al.

    The association between obesity and the frailty syndrome in older women: the women's health and aging studies

    J Am Geriatr Soc

    (2005)
  • C.T. Cigolle et al.

    Comparing models of frailty: The health and retirement study

    J Am Geriatr Soc

    (2009)
  • E.R. Wilhelm-Leen et al.

    Frailty and chronic kidney disease: the third national health and nutrition evaluation survey

    Am J Med

    (2009)
  • H. Heath et al.

    The concept of frailty and its significance in the consequences of care or neglect for older people: an analysis

    Int J Older People Nurs

    (2009)
  • M. Markle-Reid et al.

    Conceptualizations of frailty in relation to older adults

    J Adv Nurs

    (2003)
  • M.J. Levers et al.

    Factors contributing to frailty: literature review

    J Adv Nurs

    (2006)
  • D.K. Kiely et al.

    Validation and comparison of two frailty indexes: The MOBILIZE Boston study

    J Am Geriatr Soc

    (2009)
  • R. Romero-Ortuno et al.

    A frailty instrument for primary care: findings from the survey of health, ageing and retirement in Europe (SHARE)

    BMC Geriatr

    (2010)
  • N. Sourial et al.

    A correspondence analysis revealed frailty deficits aggregate and are multidimensional

    J Clin Epidemiol

    (2010)
  • Cited by (97)

    • Frailty in Korean patients with chronic obstructive pulmonary disease, using data from the Korea National Health and Nutrition Examination Survey, 2015 and 2016

      2021, Applied Nursing Research
      Citation Excerpt :

      Due to frailty's high prevalence among COPD patients, examining its determinants is of the utmost importance. Dyspnea, disease severity, comorbidities, health care use, and history of exacerbations have been associated with frailty in studies of COPD patients (Ierodiakonou et al., 2019; Limpawattana et al., 2017; Park et al., 2013). However, most of what is known about prevalence and the determinants of frailty has come from countries other than Korea.

    • New developments in COPD

      2024, Medicine Today
    View all citing articles on Scopus
    View full text